Last updated on March 2019

A Phase III, Multi-Center, Randomized, Double-Masked, Sham Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)


Brief description of study

This is a 30-month, Phase III, multicenter, randomized, double-masked, sham-injection controlled study to assess the efficacy and safety of multiple IVT injections of APL-2 in subjects with GA secondary to AMD.

 

Clinical Study Identifier: TX215724

Find a site near you

Start Over

University of South Florida-Morsani College of Medicine

13330 USF Laurel Dr. Tampa, FL United States
  Connect »